[Thrombocyte aggregation in the cat]

S Hart1, I Nolte

  • 1Klinik für kleine Haustiere der Tierärztlichen Hochschule Hannover.

Tierarztliche Praxis
|August 1, 1991
PubMed

Insights

This study details feline platelet aggregation responses to various agents. Acetylsalicylic acid (ASA) inhibits aggregation, particularly with low collagen concentrations, offering insights into feline hemostasis.

Area of Science:

  • Veterinary Hematology
  • Platelet Physiology
  • Feline Medicine

Context:

  • Understanding platelet function is crucial for diagnosing and managing feline hemostatic disorders.
  • Limited research exists on feline platelet aggregation compared to other species.
  • This study investigates the aggregation patterns of cat platelets.

Purpose:

  • To characterize the aggregation response of feline platelets to common aggregating agents.
  • To evaluate the effect of acetylsalicylic acid (ASA) on feline platelet aggregation.
  • To assess platelet function in cats with specific health conditions.

Summary:

  • Feline platelets showed irreversible aggregation with collagen, adenosine diphosphate (ADP), test-thrombin, and Topostasin, but not epinephrine, ristocetin, or kaolin.
  • Platelet aggregation was reduced in a cat with liver damage and icterus, but normal in cats with uremia.
  • Acetylsalicylic acid (ASA) inhibited collagen-induced platelet aggregation, with higher collagen concentrations overcoming this inhibition.

Impact:

  • Provides baseline data for feline platelet aggregation.
  • Highlights potential antiplatelet effects of ASA in cats.
  • Informs veterinary diagnostics and therapeutic strategies for feline bleeding disorders.